News on how the brain changes over time, how to clear foggy brains, how to multitask (or not), and more

By SharpBrains | April 28, 2022

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing time­ly brain & men­tal health news and a fun brain teas­er to test the lim­its of mul­ti-task­ing. #1. Col­lab­o­ra­tive neu­roimag­ing ini­tia­tive Brain­Chart helps chart how brains change across the lifes­pan. Among the many fas­ci­nat­ing find­ings: “The vol­ume of grey mat­ter (brain cells) increas­es rapid­ly from mid-gestation…

Read More

Could I be wrong? Exploring cognitive bias, curiosity, intellectual humility, and lifelong learning

By SharpBrains | November 30, 2021

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing eight time­ly sci­en­tif­ic and indus­try news plus a few fun teasers to appre­ci­ate our unique human brains. #1. Could I be wrong? Explor­ing research on cog­ni­tive bias, curios­i­ty, intel­lec­tu­al humil­i­ty, and life­long learn­ing “None of us thinks that our beliefs and atti­tudes are incor­rect; if we…

Read More

FDA-approved, Cybin-sponsored clinicial trial to measure ketamine’s impact on the brain via Kernel Flow neuroimaging helmet

By SharpBrains | November 22, 2021

Kernel’s Brain-Imag­ing Hel­met Approved For Clin­i­cal Tri­al On Patients Using Ket­a­mine (Forbes): The U.S. Food and Drug Admin­is­tra­tion has approved a clin­i­cal tri­al using a neu­roimag­ing hel­met made by Los Ange­les-based Ker­nel to track what hap­pens in the brain when a human takes a psy­che­del­ic dose of ketamine.

Read More

Next: Psychedelic-assisted psychotherapy?

By SharpBrains | February 4, 2021

How ecsta­sy and psilo­cy­bin are shak­ing up psy­chi­a­try (Nature): … The Impe­r­i­al study was one of a spate of clin­i­cal tri­als launched over the past few years using illic­it psy­che­del­ic drugs such as psilo­cy­bin, lyser­gic acid diethy­lamide (LSD) and MDMA (3,4‑methylenedioxymethamphetamine, also known as mol­ly or ecsta­sy) to treat men­­tal-health dis­or­ders, gen­er­al­ly with the close…

Read More

Study: Psychedelics can promote neural plasticity in the prefrontal cortex and expand pathways for mental health

By SharpBrains | August 17, 2018

Psy­che­delics in Neu­rol­o­gy: Poten­tial for Improv­ing Neu­ro­plas­tic­i­ty (Neu­rol­o­gy­Times): “Back in the 1950s, research was prov­ing that psy­che­del­ic agents could be effec­tive in the treat­ment of var­i­ous neu­ropsy­chi­atric dis­or­ders. Unfor­tu­nate­ly, just as sci­ence was explor­ing their ben­e­fi­cial effects, the coun­ter­cul­ture was explor­ing and embrac­ing their effects. Slow­ly but sure­ly, psy­che­delics were asso­ci­at­ed with rebel­lious youth and…

Read More